Re-engineered Human T Cells Effectively Target And Kill Cancerous B Cells
Human white blood cells, engineered to recognize other malignant immune cells, could provide a novel therapy for patients with highly lethal B cell cancers such as acute lymphoblastic leukemia (ALL), according to researchers at Memorial Sloan-Kettering Cancer Center (MSKCC).
By administering repeated doses of T cells designed to express an artificial receptor which recognizes human B cells, the researchers were able to eradicate cancer in 44 percent of mice bearing human ALL tumors.
Re-engineered Human T Cells Effectively Target And Kill Cancerous B Cells
(sciencedaily.com)
By administering repeated doses of T cells designed to express an artificial receptor which recognizes human B cells, the researchers were able to eradicate cancer in 44 percent of mice bearing human ALL tumors.
Re-engineered Human T Cells Effectively Target And Kill Cancerous B Cells
(sciencedaily.com)
Categories
Research and Development0 TrackBacks
Listed below are links to blogs that reference this entry: Re-engineered Human T Cells Effectively Target And Kill Cancerous B Cells.
TrackBack URL for this entry: http://stemconnect.com/cgi-bin/mt/mt-t.cgi/196
Leave a comment